Abstract:PURPOSE To compare the therapeutic outcomes of single-session gamma knife surgery (GKS) and 2-stage GKS for large (diameter ≥ 2 cm) brain metastases from lung cancer. METHODS For the first time, patients with brain metastases from a single primary tumor were selected, and the treatment data of patients with large lung brain metastases from lung adenocarcinoma treated with single-session or 2-stage GKS between January 2019 and June 2022 at our hospital were retrospectively analyzed. Seventy-seven patients (85 lesions) were in the single-session GKS group, while 62 patients (72 lesions) were in the 2-stage GKS group. Propensity score matching of cases was performed because of differences in the number of patients and clinical factors prior to GKS between the two groups. Finally, 90 patients (45 in each group) were included in the matched case-control study. Therapeutic outcomes were measured based on the Karnofsky performance status score, local tumor control, cumulative incidence of radiation necrosis, and overall survival of each patient. RESULTS In the overall patient cohort, the cumulative incidence of radiation necrosis was significantly lower in the staged GKS group than in the single-session GKS group (5.0% vs. 18.4% at 1 year, p = 0.028). In the case-matched cohort, the cumulative incidence of neurological death was significantly lower in the staged GKS group than in the single-session GKS group (2.4% vs. 4.9% at 1 year, p = 0.045). In both the overall and case-matched cohorts, the rate of tumor volume change after GKS was significantly higher in the staged GKS group (67.5%, 67.5%) than in the single-session GKS group (53.0, 51.1%) (p < 0.05). The local tumor control and rate of tumor volume change were also significantly better in the staged GKS group than in the single-session GKS group. No significant difference in overall survival was observed between the two groups. Besides, the rate of tumor volume change is a significant factor that influences the long-term efficacy of local tumor control. Additionally, the control of the primary tumor is an independent influencing factor for the overall survival of patients. CONCLUSION Our findings suggest that staged GKS is safer and more efficacious than single-session GKS for large brain metastases (≥ 2 cm in diameter) from lung adenocarcinoma, and that the rate of tumor volume change after treatment influences local tumor progression.

Treatment of intracranial metastatic tumors

Gamma Knife Surgery for Brain Metastasis from Hepatocellular Carcinoma.

Clinical Study of Mailgnant Brain Gliomas Treated by Interstitial Radiotherapy and Interstitial Chemotherapy

Comparison of Treatment Outcomes of Single-Session and 2-Stage Gamma Knife Surgery for Large Brain Metastases from Lung Adenocarcinoma

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

[Treatment and Prognosis of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Study].

Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review

The Current Situation and Advances in the Whole Brain Radiation Therapy for Newly-diagnosed Brain Metastases

[Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis].

The Analysis of Effect about Different Therapies on Brain Metastases from Non-Small Cell Lung Cancer

Clinical Study of Fractionated Stereotactic Radiotherapy in Patients with Intracranial Metastatic Tumors

[Whole Brain Irradiation for Non-Small-cell Lung Cancer with Brain Metastasis].

Gamma knife surgery for the treatment of brain metastases

The genetic and biochemical basis of Omenn syndrome

Prognosis and Survival for 214 Lung Cancer Patients with Brain Metastases

Conformal Radiotherapy and Prognosis of Patients with Brain Metastases

Radiotherapy in combination with systemic therapies for brain metastases: current status and progress

CLONIDINE IN BENZODIAZEPINE WITHDRAWAL

Rationale, study design, and pilot phase of tHE Management of AntiThrOMbotic therApy (HEMATOMA) in patients undergoing electrophysiological device surgery: Italian National Multicenter Observational REgistry

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis.

Treatment and survival of patients with small cell lung cancer and brain metastasis